Randomized Controlled Clinical Trial of "Virtual House Calls" for Parkinson Disease

被引:163
|
作者
Dorsey, E. Ray [1 ]
Venkataraman, Vinayak [1 ]
Grana, Matthew J. [3 ]
Bull, Michael T. [3 ]
George, Benjamin P. [6 ]
Boyd, Cynthia M. [2 ]
Beck, Christopher A. [4 ]
Rajan, Balaraman [5 ]
Seidmann, Abraham [5 ]
Biglan, Kevin M. [3 ]
机构
[1] Johns Hopkins Med, Dept Neurol, Baltimore, MD 21287 USA
[2] Johns Hopkins Med, Dept Med, Baltimore, MD 21287 USA
[3] Univ Rochester, Med Ctr, Dept Neurol, New York, NY USA
[4] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, New York, NY USA
[5] Univ Rochester, William E Simon Grad Sch Business Adm, New York, NY USA
[6] Univ Rochester, Sch Med & Dent, New York, NY USA
关键词
DEEP-BRAIN-STIMULATION; CARE; TELEMEDICINE; SATISFACTION; VALIDATION;
D O I
10.1001/jamaneurol.2013.123
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Importance: The burden of neurological disorders is increasing, but access to care is limited. Providing specialty care to patients via telemedicine could help alleviate this growing problem. Objective: To evaluate the feasibility, effectiveness, and economic benefits of using web-based videoconferencing (telemedicine) to provide specialty care to patients with Parkinson disease in their homes. Design: A 7-month, 2-center, randomized controlled clinical trial. Setting: Patients' homes and outpatient clinics at 2 academic medical centers. Participants: Twenty patients with Parkinson disease with Internet access at home. Intervention: Care from a specialist delivered remotely at home or in person in the clinic. Main Outcome Measures: The primary outcome variable was feasibility, as measured by the percentage of telemedicine visits completed as scheduled. Secondary outcome measures included clinical benefit, as measured by the 39-item Parkinson Disease Questionnaire, and economic value, as measured by time and travel. Results: Twenty participants enrolled in the study and were randomly assigned to telemedicine (n=9) or in-person care (n=11). Of the 27 scheduled telemedicine visits, 25 (93%) were completed, and of the 33 scheduled in-person visits, 30 (91%) were completed (P=.99). In this small study, the change in quality of life did not differ for those randomly assigned to telemedicine compared with those randomly assigned to in-person care (4.0-point improvement vs 6.4-point improvement; P=.61). Compared with in-person visits, each telemedicine visit saved participants, on average, 100 miles of travel and 3 hours of time. Conclusion and Relevance: Using web-based videoconferencing to provide specialty care at home is feasible, provides value to patients, and may offer similar clinical benefit to that of in-person care. Larger studies are needed to determine whether the clinical benefits are indeed comparable to those of in-person care and whether the results observed are generalizable.
引用
收藏
页码:565 / 570
页数:6
相关论文
共 50 条
  • [1] National randomized controlled trial of virtual house calls for Parkinson disease
    Beck, Christopher A.
    Beran, Denise B.
    Biglan, Kevin M.
    Boyd, Cynthia M.
    Dorsey, E. Ray
    Schmidt, Peter N.
    Simone, Richard
    Willis, Allison W.
    Galifianakis, Nicholas B.
    Katz, Maya
    Tanner, Caroline M.
    Dodenhoff, Kristen
    Aldred, Jason
    Carter, Julie
    Fraser, Andrew
    Jimenez-Shahed, Joohi
    Hunter, Christine
    Spindler, Meredith
    Reichwein, Suzanne
    Mari, Zoltan
    Dunlop, Becky
    Morgan, John C.
    McLane, Dedi
    Hickey, Patrick
    Gauger, Lisa
    Richard, Irene Hegeman
    Mejia, Nicte I.
    Bwala, Grace
    Nance, Martha
    Shih, Ludy C.
    Singer, Carlos
    Vargas-Parra, Silvia
    Zadikoff, Cindy
    Okon, Natalia
    Feigin, Andrew
    Ayan, Jean
    Vaughan, Christina
    Pahwa, Rajesh
    Dhall, Rohit
    Hassan, Anhar
    DeMello, Steven
    Riggare, Sara S.
    Wicks, Paul
    Achey, Meredith A.
    Elson, Molly J.
    Goldenthal, Steven
    Keenan, H. Tait
    Korn, Ryan
    Schwarz, Heidi
    Sharma, Saloni
    NEUROLOGY, 2017, 89 (11) : 1152 - 1161
  • [2] Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial
    Achey, Meredith A.
    Beck, Christopher A.
    Beran, Denise B.
    Boyd, Cynthia M.
    Schmidt, Peter N.
    Willis, Allison W.
    Riggare, Sara S.
    Simone, Richard B.
    Biglan, Kevin M.
    Dorsey, E. Ray
    TRIALS, 2014, 15
  • [3] Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial
    Meredith A Achey
    Christopher A Beck
    Denise B Beran
    Cynthia M Boyd
    Peter N Schmidt
    Allison W Willis
    Sara S Riggare
    Richard B Simone
    Kevin M Biglan
    E Ray Dorsey
    Trials, 15
  • [4] Erratum To: Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial
    Meredith A. Achey
    Christopher A. Beck
    Denise B. Beran
    Cynthia M. Boyd
    Peter N. Schmidt
    Allison W. Willis
    Sara S. Riggare
    Richard B. Simone
    Kevin M. Biglan
    E. Ray Dorsey
    Trials, 17
  • [5] National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers
    Dorsey, E. Ray
    Achey, Meredith A.
    Beck, Christopher A.
    Beran, Denise B.
    Biglan, Kevin M.
    Boyd, Cynthia M.
    Schmidt, Peter N.
    Simone, Richard
    Willis, Allison W.
    Galifianakis, Nicholas B.
    Katz, Maya
    Tanner, Caroline M.
    Dodenhoff, Kristen
    Ziman, Nathan
    Aldred, Jason
    Carter, Julie
    Jimenez-Shahed, Joohi
    Hunter, Christine
    Spindler, Meredith
    Mari, Zoltan
    Morgan, John C.
    McLane, Dedi
    Hickey, Patrick
    Gauger, Lisa
    Richard, Irene Hegeman
    Bull, Michael T.
    Mejia, Nicte I.
    Bwala, Grace
    Nance, Martha
    Shih, Ludy
    Anderson, Lauren
    Singer, Carlos
    Zadikoff, Cindy
    Okon, Natalia
    Feigin, Andrew
    Ayan, Jean
    Vaughan, Christina
    Pahwa, Rajesh
    Cooper, Jessica
    Webb, Sydney
    Dhall, Rohit
    Hassan, Anhar
    Weis, Delana
    DeMello, Steven
    Riggare, Sara S.
    Wicks, Paul
    Smith, Joseph
    Keenan, H. Tait
    Korn, Ryan
    Schwarz, Heidi
    TELEMEDICINE AND E-HEALTH, 2016, 22 (07) : 590 - 598
  • [6] Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial (vol 15, 465, 2014)
    Achey, Meredith A.
    Beck, Christopher A.
    Beran, Denise B.
    Boyd, Cynthia M.
    Schmidt, Peter N.
    Willis, Allison W.
    Riggare, Sara S.
    Simone, Richard B.
    Biglan, Kevin M.
    Dorsey, E. Ray
    TRIALS, 2016, 17
  • [7] Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial
    Hartmann, Andreas
    Mullner, Julia
    Meier, Niklaus
    Hesekamp, Helke
    van Meerbeeck, Priscilla
    Habert, Marie-Odile
    Kas, Aurelie
    Tanguy, Marie-Laure
    Mazmanian, Merry
    Oya, Herve
    Abuaf, Nissen
    Gaouar, Hafida
    Salhi, Sabrina
    Charbonnier-Beaupel, Fanny
    Fievet, Marie-Helene
    Galanaud, Damien
    Arguillere, Sophie
    Roze, Emmanuel
    Degos, Bertrand
    Grabli, David
    Lacomblez, Lucette
    Hubsch, Cecile
    Vidailhet, Marie
    Bonnet, Anne-Marie
    Corvol, Jean-Christophe
    Schupbach, Michael
    PLOS ONE, 2016, 11 (07):
  • [8] Effect of group virtual exercise on people with Parkinson's disease: A randomized controlled trial
    Fishel, Sarah C.
    Hotchkiss, Megan E.
    McNamara, Christine A.
    Sevilla, Kaitlyn M.
    Brown, Samantha A.
    PHYSIOTHERAPY THEORY AND PRACTICE, 2024,
  • [9] IMMERSIVE VIRTUAL REALITY AS A COMPLEMENT TO PHYSICAL THERAPY FOR PARKINSON'S DISEASE - A RANDOMIZED CONTROLLED TRIAL
    Silva, D. Pimenta
    Pona-Ferreira, F.
    Santos, B.
    Rodrigues, C. Correia
    Xavier, A.
    Silva, C. Santos
    Cacho, R.
    Bouca-Machado, R.
    Campo-Pietro, P.
    Ferreira, J. J.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [10] The impact of physician house calls on the utilization of the sponsoring hospital: A randomized controlled trial.
    Haydar, ZR
    Lowe, J
    Kahveci, K
    Shofner, S
    Weatherford, W
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (04) : S34 - S34